Exosomal microRNA-29a mediates cardiac dysfunction and mitochondrial inactivity in obesity-related cardiomyopathy
Purpose Present study aims to explore the pathophysiological role of microRNA (miR)-29a in the process of obesity-related cardiomyopathy in human subjects and mice. Methods The expression level of circulating exosomal miR-29a was measured in 37 lean and 30 obese human subjects, and correlated with c...
Saved in:
Published in | Endocrine Vol. 63; no. 3; pp. 480 - 488 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.03.2019
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 1355-008X 1559-0100 1559-0100 |
DOI | 10.1007/s12020-018-1753-7 |
Cover
Summary: | Purpose
Present study aims to explore the pathophysiological role of microRNA (miR)-29a in the process of obesity-related cardiomyopathy in human subjects and mice.
Methods
The expression level of circulating exosomal miR-29a was measured in 37 lean and 30 obese human subjects, and correlated with cardiac parameters. The effects of miR-29a on mitochondrial activity and cardiac function were investigated by treatment of miR-29a sponge in primary mouse cardiomyocytes and diet-induced obesity-related cardiomyopathy in mice.
Results
The increased circulating miR-29a level was closely associated with impaired human cardiac function, including ejection fraction (
r
= −0.2663,
p
< 0.05) and NT-proBNP levels (
r
= 0.4270,
p
< 0.001). Exosomes from obese human plasma mediated cardiomyocyte mitochondrial inactivity, but pre-treatment with miR-29a sponge attenuated the exosomal miR-29a-induced reduction of ATP production (
p
< 0.001), basal oxygen consumption (
p
< 0.01) and mitochondrial complex I activity (
p
< 0.01). In vivo mouse study, high fat diet damaged cardiac function, normal structure, and mitochondrial activity, whereas miR-29a sponge improved the cardiac status.
Conclusions
Present study uncovered the correlation between circulating miR-29a and cardiac parameters in human subjects, and provided solid evidence of the therapeutic application of miR-29a sponge in combating obesity-mediated cardiac dysfunction. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 1355-008X 1559-0100 1559-0100 |
DOI: | 10.1007/s12020-018-1753-7 |